Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Experimental Neurology|October 16, 2021
Impact of intermittent hypoxia on human vascular responses during sleepAndrew E Beaudin, Patrick J Hanly, Jill K Raneri, et al.
Clinical Cardiology|September 29, 2021
Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence studyGuanmin Chen, Megan S Farris, Tara Cowling, et al.
Heart Rhythm|May 3, 2008
Polymorphisms in multiple genes are associated with resting heart rate in a stepwise allele-dependent mannerStephen B Wilton, Todd J Anderson, Jillian Parboosingh, et al.
Atherosclerosis|May 15, 2009
The differential association between various anthropometric indices of obesity and subclinical atherosclerosisRaymond T Yan, Andrew T Yan, Todd J Anderson, et al.
Atherosclerosis|July 27, 2025
Characterization of lipoprotein (a) testing in Alberta, Canada: a retrospective cohort studyPhongsack Manivong, Eileen Shaw, Tram Pham, et al.
The Canadian Journal of Cardiology|June 3, 2014
Preparing today's cardiovascular trainees to meet the challenges of tomorrow: team research and interdisciplinary trainingAlexander M Clark, Kelly A D Narine, Zoe Y Hsu, et al.
Echocardiography (Mount Kisco, N.Y.)|October 31, 2018
Impact of contrast echocardiography on accurate discrimination of specific degree of left ventricular systolic dysfunction and comparison with cardiac magnetic resonance imagingAws Alherbish, Harald Becher, Wendimagegn Alemayehu, et al.
Cardiology and Therapy|January 19, 2023
Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9iErin S Mackinnon, Bryan Har, Salimah Champsi, et al.
Cardiovascular Research|August 11, 2007
Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteriesMatthew I Worthley, Ronak S Kanani, Yi-Hui Sun, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2005
A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) miceAndrew G Howarth, William B Wiehler, Malarvannan Pannirselvam, et al.
Pageof 15